NCT05813964 - Efficacy, Acceptability and Safety of Event-driven HIV PrEP Using TAF/FTC in MSM in Thailand and France. | Biotech Hunter

Enrollment

524

Participants

Timeline

Start Date

June 5, 2024

Primary Completion Date

October 31, 2026

Study Completion Date

May 31, 2027

Conditions

HIV/AIDS

Interventions

DRUG

TDF/FTC 300mg/200mg fixed-dose combination tablets

Event-driven dosing regimen

DRUG

TAF/FTC 25mg/200mg fixed-dose combination tablets

Event-driven dosing regimen.

Trial Locations (4)

RECRUITING

AP-HP - Hospital Lariboisière, Paris

RECRUITING

AP-HP - Hôpital Saint-Louis, Paris

RECRUITING

MPlus Clinic, Chiang Mai

RECRUITING

STIs Clinic of the Office of Disease Prevention and Control Region 1, Chiang Mai